Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic Study to Assess and Compare the Pharmacokinetics of Enrofloxacin After Dermal, Inhaled, and Oral Dosing

NCT03575312 is registered in ClinicalTrials.gov with Fraunhofer-Institute of Toxicology and Experimental Medicine as lead sponsor.

NCT NCT03575312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03575312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic Study to Assess and Compare the Pharmacokinetics of Enrofloxacin After Dermal, Inhaled, and Oral Dosing
Lead sponsor
Fraunhofer-Institute of Toxicology and Experimental Medicine
Phase
Not applicable
Overall status
Completed
Start date
April 27, 2018
Completion date
August 30, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy